CAS Number 1259933-16-8 ChemSpider 34500834 Molar mass 429.3455 g/mol | ATC code None PubChem CID 49836093 UNII E3COJ2T10W | |
 | ||
Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by Xenon Pharmaceuticals in partnership with Teva Pharmaceutical Industries for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.
References
Funapide Wikipedia(Text) CC BY-SA